Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

1. Flu vaccination in schools

Flu vaccination in schools Flu vaccination in schools - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Flu vaccination in schools Flu vaccination guidance and resources for schools. Published 11 May 2017 Last updated 24 July 2020 — From: Documents Ref: PHE (...) 2020114 MS Word Document , 142KB This file may not be suitable for users of assistive technology. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details Resources to support flu vaccination in schools. Advice for school teams This guidance has been produced to assist all school staff and headteachers with any

2020 Public Health England

2. A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study Full Text available with Trip Pro

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Wayne State University School of Medicine, Detroit Medical Center, Detroit, Michigan, USA. 2 Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 3 University Hospital of Tours, Tours, France. 4 Infectious Disease Research Unit, Department of Translational Medicine, Skåne

2020 EvidenceUpdates

3. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study

Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Diabetes Care Actions . 2020 Jul 9;dc200229. doi: 10.2337/dc20-0229. Online ahead of print. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes

2020 EvidenceUpdates

4. Avian influenza A(H5N1): risk assessment

Avian influenza A(H5N1): risk assessment Avian influenza A(H5N1): risk assessment - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Avian influenza A(H5N1): risk assessment The risk to UK residents travelling to the affected areas is very low. Published 8

2020 Public Health England

5. Avian influenza A(H7N4): risk assessment

Avian influenza A(H7N4): risk assessment Avian influenza A(H7N4): risk assessment - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Avian influenza A(H7N4): risk assessment Public Health England risk assessment of avian influenza A(H7N4) following reports (...) of the first human case in a person from China. Published 17 April 2018 Last updated 17 July 2020 — From: Documents Ref: PHE publications gateway number 2017897 HTML Details Since the World Health Organization ( 17 July 2020 Update July 2020: no further cases were reported. 16 April 2019 Updated review of Public Health England’s risk assessment for Avian influenza A(H7N4) to confirm that no further cases have been reported since April 2018. 17 April 2018 First published. Related content Collection Explore

2020 Public Health England

6. Scoping report - universal influenza vaccination in children

controlled trial RTI Respiratory tract infection SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 WHO World Health Organization Scoping report: Universal Influenza vaccination in children Health Information and Quality Authority Page 6 of 24 Purpose The purpose of this report is to provide a preliminary assessment of the currently available evidence (including ongoing research) for universal influenza vaccination of children in order to inform consideration by the Minister for Health of its (...) 80 million doses of LAIV had been distributed, mostly in the US, including over 50,000 doses as part of its clinical development programme; the vaccine was generally well-tolerated. While LAIV has not been associated with an increase in hospitalisations, nor higher rates of anaphylaxis, Guillain-Scoping report: Universal Influenza vaccination in children Health Information and Quality Authority Page 13 of 24 Barré syndrome or encephalitis, it is noted that studies are typically not powered

2020 Health Information and Quality Authority

7. Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults

Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show account info Close Account (...) navigation J Infect Dis Actions . 2020 May 14;jiaa255. doi: 10.1093/infdis/jiaa255. Online ahead of print. Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults , , , , , , , , , Affiliations Expand Affiliations 1 World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China. 2 Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA

2020 EvidenceUpdates

8. Risk for Subdeltoid Bursitis After Influenza Vaccination: A Population-Based Cohort Study. (Abstract)

Risk for Subdeltoid Bursitis After Influenza Vaccination: A Population-Based Cohort Study. Subdeltoid bursitis has been reported as an adverse event after intramuscular vaccination in the deltoid muscle. Most published case reports involved influenza vaccine.To estimate the risk for subdeltoid bursitis after influenza vaccination.Retrospective cohort study.The Vaccine Safety Datalink, which contains health encounter data for 10.2 million members of 7 U.S. health care organizations.Persons who (...) received an inactivated influenza vaccine during the 2016-2017 influenza season.Potential incident cases were identified by searching administrative data for persons with a shoulder bursitis diagnostic code within 180 days after receiving an injectable influenza vaccine in the same arm. The date of reported bursitis symptom onset was abstracted from the medical record. A self-controlled risk interval analysis was used to calculate the incidence rate ratio of bursitis in a risk interval of 0 to 2 days

2020 Annals of Internal Medicine

9. Historical Insights on Coronavirus Disease 2019 (COVID-19), the 1918 Influenza Pandemic, and Racial Disparities: Illuminating a Path Forward. Full Text available with Trip Pro

Historical Insights on Coronavirus Disease 2019 (COVID-19), the 1918 Influenza Pandemic, and Racial Disparities: Illuminating a Path Forward. The coronavirus disease 2019 (COVID-19) pandemic is exacting a disproportionate toll on ethnic minority communities and magnifying existing disparities in health care access and treatment. To understand this crisis, physicians and public health researchers have searched history for insights, especially from a great outbreak approximately a century ago (...) : the 1918 influenza pandemic. However, of the accounts examining the 1918 influenza pandemic and COVID-19, only a notable few discuss race. Yet, a rich, broader scholarship on race and epidemic disease as a "sampling device for social analysis" exists. This commentary examines the historical arc of the 1918 influenza pandemic, focusing on black Americans and showing the complex and sometimes surprising ways it operated, triggering particular responses both within a minority community and in wider racial

2020 Annals of Internal Medicine

10. Effect of Patient Portal Reminders Sent by a Health Care System on Influenza Vaccination Rates: A Randomized Clinical Trial

Effect of Patient Portal Reminders Sent by a Health Care System on Influenza Vaccination Rates: A Randomized Clinical Trial Effect of Patient Portal Reminders Sent by a Health Care System on Influenza Vaccination Rates: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health (...) Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation JAMA Intern Med Actions . 2020 May 18;e201602. doi: 10.1001/jamainternmed.2020.1602. Online ahead of print. Effect of Patient Portal Reminders Sent by a Health Care System on Influenza Vaccination Rates: A Randomized Clinical Trial , , , , , , , , , , , , Affiliations Expand Affiliations 1 Department of Pediatrics, UCLA (University of California, Los Angeles) Mattel Children's Hospital

2020 EvidenceUpdates

11. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis Full Text available with Trip Pro

Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis Efficacy and Safety of Corticosteroids in COVID-19 Based on Evidence for COVID-19, Other Coronavirus Infections, Influenza, Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript (...) Coronavirus Infections, Influenza, Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis , , , , , , , , , , , , , , Affiliations Expand Affiliation 1 Department of Health Research Methods, Evidence and Impact (Ye, Tangamornsuksan, Rochwerg, Guyatt, Colunga-Lozano, Yao, Motaghi, Fang, Xiao), McMaster University, Hamilton, Ont.; Department of Pharmacy (Wang), Beijing Chaoyang Hospital, Capital Medical University, Beijing, China; Department of Clinical

2020 EvidenceUpdates

12. Fluad Tetra influenza vaccine (surface antigen, inactivated, adjuvanted)

vaccine (surface antigen, inactivated, adjuvanted)) An overview of Fluad Tetra and why it is authorised in the EU What is Fluad Tetra and what is it used for? Fluad Tetra is a vaccine used to protect people aged from 65 years against influenza (flu). Flu is caused mainly by two types of influenza virus, known as influenza A and B. Each of these circulate as different strains, which change over time. Fluad Tetra will contain proteins from four different inactivated influenza A and B virus strains (two (...) strains of type A influenza virus of the subtypes H1N1 and H3N2 and two type B strains). They are chosen according to the official recommendation for the annual flu season. The vaccine also contains an adjuvant, which helps to improve the vaccine's effectiveness. The viruses used for producing Fluad Tetra are grown in fertilized hens’ eggs. How is Fluad Tetra used? Fluad Tetra is available as an injection in a pre-filled syringe. The recommended dose is a single injection (of 0.5 ml) into a muscle

2020 European Medicines Agency - EPARs

13. Influenza vaccine: ovalbumin content

Influenza vaccine: ovalbumin content Influenza vaccine: ovalbumin content - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Influenza vaccine: ovalbumin content Data on the ovalbumin content of the influenza vaccines for the 2020 to 2021 flu season. Published (...) 29 July 2016 Last updated 10 June 2020 — From: Documents Ref: PHE publications gateway number 2019056 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This table lists all of the ovalbumin content of the influenza vaccines that are marketed in the UK for the 2020 to 2021 flu vaccination season

2020 Public Health England

14. Baloxavir marboxil (Xofluza) - influenza

Baloxavir marboxil (Xofluza) - influenza Search Page - Drug and Health Product Register Language selection Search and menus Search Search website Search Topics menu You are here: Summary Basis of Decision - - Health Canada Expand all Summary Basis of Decision (SBD) for Contact: Summary Basis of Decision (SBD) documents provide information related to the original authorization of a product. The for is located below. Recent Activity for SBDs written for approved after September 1, 2012

2020 Health Canada - Drug and Health Product Register

15. Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations

Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology (...) Actions . 2020 Mar;145(3):e20191909. doi: 10.1542/peds.2019-1909. Epub 2020 Feb 6. Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations , , , , , , , , Affiliations Expand Affiliations 1 Department of Pediatrics and walte002@mc.duke.edu. 2 Duke Human Vaccine Institute, School of Medicine, Duke University, Durham, North Carolina. 3 Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California; and. 4 Immunization Safety Office

2020 EvidenceUpdates

16. Do Corticosteroids Benefit Patients With Influenza Pneumonia? Full Text available with Trip Pro

Do Corticosteroids Benefit Patients With Influenza Pneumonia? Do Corticosteroids Benefit Patients With Influenza Pneumonia? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page To read this article in full, please review your options for gaining access at the bottom of the page. Article in Press Do Corticosteroids Benefit Patients With Influenza Pneumonia? x Michael Gottlieb , MD (EBEM Commentator) , x Thomas Seagraves , MD (EBEM (...) Commentator) , x Stephen R. Gore , MD (EBEM Commentator) Department of Emergency Medicine, Rush University Medical Center, Chicago, IL DOI: Publication History Published online: July 23, 2019 To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Among patients with influenza pneumonia, corticosteroids are associated with increased mortality, longer length of stay in the ICU, and higher rates of secondary infection, although there are no data from

2020 Annals of Emergency Medicine Systematic Review Snapshots

17. The Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality: An Observational Study With a Regression Discontinuity Design. (Abstract)

The Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality: An Observational Study With a Regression Discontinuity Design. Observational studies using traditional research designs suggest that influenza vaccination reduces hospitalizations and mortality among elderly persons. Accordingly, health authorities in some countries prioritize vaccination of this population. Nevertheless, questions remain about this policy's effectiveness given the potential for bias (...) and confounding in observational data.To determine the effectiveness of the influenza vaccine in reducing hospitalizations and mortality among elderly persons by using an observational research design that reduces the possibility of bias and confounding.A regression discontinuity design was applied to the sharp change in vaccination rate at age 65 years that resulted from an age-based vaccination policy in the United Kingdom. In this design, comparisons were limited to individuals who were near the age-65

2020 Annals of Internal Medicine

18. Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial. (Abstract)

Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial. FLU-v is a broad-spectrum influenza vaccine that induces antibodies and cell-mediated immunity.To compare the safety, immunogenicity, and exploratory efficacy of different formulations and dosing regimens of FLU-v versus placebo.Randomized, double-blind, placebo-controlled, single-center phase 2b clinical trial. (ClinicalTrials.gov: NCT02962908; EudraCT: 2015 (...) vaccine efficacy against influenza infection.Adjuvanted FLU-v is immunogenic and merits phase 3 development to explore efficacy.SEEK and the European Commission Directorate-General for Research and Innovation, European Member States within the UNISEC (Universal Influenza Vaccines Secured) project.

2020 Annals of Internal Medicine

19. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Full Text available with Trip Pro

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Antivirals are infrequently prescribed in European primary care for influenza-like illness, mostly because of perceived ineffectiveness in real world primary care and because individuals who will especially benefit have not been identified in independent trials. We aimed to determine whether adding antiviral treatment to usual primary care for patients (...) with influenza-like illness reduces time to recovery overall and in key subgroups.We did an open-label, pragmatic, adaptive, randomised controlled trial of adding oseltamivir to usual care in patients aged 1 year and older presenting with influenza-like illness in primary care. The primary endpoint was time to recovery, defined as return to usual activities, with fever, headache, and muscle ache minor or absent. The trial was designed and powered to assess oseltamivir benefit overall and in 36 prespecified

2020 Lancet

20. Avian influenza: guidance for managing human cases

Avian influenza: guidance for managing human cases Avian influenza: guidance for managing human cases - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Avian influenza: guidance for managing human cases Information to assist with the management of possible and confirmed human (...) cases of avian influenza. Published 12 February 2014 Last updated 13 January 2020 — From: Documents Ref: PHE publications gateway number: GW-1025 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format

2020 Public Health England